Physician

Vinod Mathew Varki, M.D.

According to 2025 Medicare claims, Vinod Varki, M.D. (NPI: 1619266798) practices hematology/oncology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Passaic, NJ. This provider's primary affiliated billing organization is REGIONAL CANCER CARE ASSOCIATES LLC (NPI: 1801850243; TIN: 223141761) and primary practice location at 07457-0017.

Varki's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 302 traditional Medicare patients, billed 123,298 HCPCS/CPT codes, and received $2,203,587 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 96 prescription claims across 44 beneficiaries totaling $18,798 in drug costs, led by Eliquis (Apixaban). DME data shows 51 claims. Open Payments data shows 35 records totaling $4,326. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $78,364 and ending at $2,203,587. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $92,045 and ending at $18,798. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	152	4,868	$78,364
2018	580	72,559	$812,769
2019	848	147,304	$1,999,610
2020	842	102,282	$1,645,282
2021	796	91,441	$1,074,737
2022	485	31,295	$231,278
2023	264	123,487	$1,240,608
2024	302	123,298	$2,203,587

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	42	132	$92,045
2016	40	115	$6,616
2017	43	100	$8,131
2018	111	457	$99,684
2019	130	511	$170,140
2020	116	375	$100,448
2021	93	200	$289,112
2022	68	153	$128,773
2023	32	108	$61,167
2024	44	96	$18,798

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	15	$3,974
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	198	$4,000
2022	N/R	108	$2,671
2023	N/R	141	$8,571
2024	N/R	51	$1,230

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	157	669	$108
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	176	399	$74
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	93	420	$14
36415	Insertion of needle into vein for collection of blood sample	214	757	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	264	1,414	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	15	600	$11,523
Letrozole	Letrozole	14	720	$388

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	17	$582
J9190	Injection, fluorouracil, 500 mg	N	N/R	17	$341
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	17	$307

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	35	$4,326	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Vinod Mathew Varki, M.D.?

Tedicare shows public-source Medicare data for Vinod Mathew Varki, M.D. (NPI 1619266798), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vinod Mathew Varki, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Vinod Mathew Varki, M.D.?

Vinod Mathew Varki, M.D. is linked to REGIONAL CANCER CARE ASSOCIATES LLC (billing NPI 1801850243) in the available physician profile data.

Does Vinod Mathew Varki, M.D. have Open Payments data?

Vinod Mathew Varki, M.D. has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.